2.46
Schlusskurs vom Vortag:
$2.65
Offen:
$2.68
24-Stunden-Volumen:
137.02K
Relative Volume:
0.54
Marktkapitalisierung:
$14.43M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-22.76M
KGV:
-0.2682
EPS:
-9.1712
Netto-Cashflow:
$-27.90M
1W Leistung:
-30.85%
1M Leistung:
-52.61%
6M Leistung:
-72.08%
1J Leistung:
-88.13%
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Firmenname
Reviva Pharmaceuticals Holdings Inc
Sektor
Branche
Telefon
(408) 501-8881
Adresse
10080 N WOLFE ROAD, CUPERTINO
Compare RVPH vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
2.47 | 15.48M | 0 | -22.76M | -27.90M | -9.1712 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.45 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
743.82 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
702.75 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.81 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
283.80 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-05 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2025-09-29 | Eingeleitet | Chardan Capital Markets | Buy |
| 2023-09-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-06-08 | Eingeleitet | The Benchmark Company | Speculative Buy |
| 2022-01-24 | Eingeleitet | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Aktie (RVPH) Neueste Nachrichten
Breakout Watch: How correlated is Reviva Pharmaceuticals Holdings Inc to the S P5002026 Rallies & AI Enhanced Execution Alerts - baoquankhu1.vn
Volume Summary: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant a good ESG investmentInflation Watch & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Reviva Pharmaceuticals to implement 1-for-20 reverse stock split on March 9 - Investing.com Nigeria
D. Boral Capital downgrades Reviva Pharmaceuticals stock rating to hold By Investing.com - Investing.com Nigeria
Reviva Pharmaceuticals Holdings (RVPH) Starts 1-for-20 Reverse Split as Nasdaq Deadline Nears - TechStock²
US Market Wrap: Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant announce a stock splitPortfolio Value Report & Safe Investment Capital Preservation Plans - baoquankhu1.vn
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock reacts to inflationary pressures2025 Pullback Review & Weekly High Potential Stock Alerts - Naître et grandir
Reviva Pharmaceuticals Announces Major Share Consolidation Plan - AD HOC NEWS
CEO Moves: Is now the right time to enter Reviva Pharmaceuticals Holdings Inc2025 Market WrapUp & Risk Controlled Swing Alerts - baoquankhu1.vn
Reviva Pharmaceuticals (RVPH) Downgraded to Hold by D. Boral Cap - GuruFocus
D. Boral Capital downgrades Reviva Pharmaceuticals stock rating to hold - Investing.com
Reviva Pharmaceuticals Announces One-for-Twenty Reverse Stock Split - TipRanks
Reviva Pharmaceuticals to implement 1-for-20 reverse stock split on March 9 By Investing.com - Investing.com India
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
RVPH PE Ratio & Valuation, Is RVPH Overvalued - Intellectia AI
Risks Report: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant in a bullish channel2025 Price Momentum & Real-Time Volume Analysis - baoquankhu1.vn
Rate Hike: Can Reviva Pharmaceuticals Holdings Inc Equity Warrant stock outperform in a bear marketShort Setup & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Levels Update: Will Reviva Pharmaceuticals Holdings Inc benefit from sector rotationJuly 2025 WrapUp & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Aug Sentiment: How sensitive is Reviva Pharmaceuticals Holdings Inc Equity Warrant to inflation2025 Stock Rankings & Smart Allocation Stock Tips - baoquankhu1.vn
Trade Report: Is Reviva Pharmaceuticals Holdings Inc exposed to currency risks2025 Price Momentum & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Guidance Update: Is Reviva Pharmaceuticals Holdings Inc forming a bullish divergenceJuly 2025 Retail & Free Verified High Yield Trade Plans - baoquankhu1.vn
Earnings Beat: Does Flywire Corporation stock have upside surprise potentialJuly 2025 Setups & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Reviva Pharmaceuticals Holdings (RVPH) and Prenetics Group (PRE) - The Globe and Mail
What technical signals suggest for Reviva Pharmaceuticals Holdings Inc. stockJuly 2025 Market Mood & Real-Time Market Trend Scan - mfd.ru
Loss Report: Is ProShares Trust ProShares UltraPro MidCap400 stock forming a cup and handle2025 Volume Leaders & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Market Pulse: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant a good ESG investment2025 Top Gainers & Weekly High Return Forecasts - baoquankhu1.vn
Aug Spikes: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant in a bullish channelJuly 2025 Final Week & Weekly Breakout Watchlists - baoquankhu1.vn
Schizophrenia Market: Expanding Revenue Landscape to 2034 - openPR.com
Schizophrenia Market: Expanding Revenue Landscape to 2034 – DelveInsight | Teva Pharma, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharma, Reviva Pharma, Minerva Neurosciences - Barchart.com
Insider Sell: Is AMHPRG part of any ETF2025 Year in Review & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock outperform in a bear marketShort Setup & Smart Investment Allocation Tips - mfd.ru
Can Reviva Pharmaceuticals Holdings Inc. stock surprise with earnings upsideQuarterly Trade Summary & Free Risk Controlled Daily Trade Plans - mfd.ru
Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock outperform tech sector in 2025Weekly Profit Report & Safe Entry Momentum Stock Tips - mfd.ru
Why is Reviva Pharmaceuticals Holdings Inc. stock going down2025 Market Trends & Low Risk Entry Point Guides - mfd.ru
How Reviva Pharmaceuticals Holdings Inc. stock compares to industry benchmarksJuly 2025 Decliners & High Accuracy Swing Entry Alerts - mfd.ru
What’s Reviva Pharmaceuticals Holdings Inc.’s historical returnWeekly Profit Summary & Growth Focused Stock Pick Reports - mfd.ru
Growth Value: Will Quetta Acquisition Corporation Equity Right outperform its industry peersFed Meeting & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant announce a stock splitJuly 2025 Price Swings & Weekly High Return Stock Opportunities - mfd.ru
How sensitive is Reviva Pharmaceuticals Holdings Inc. Equity Warrant to inflationWeekly Stock Summary & Proven Capital Preservation Tips - mfd.ru
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock performs in weak economy2025 Volume Leaders & Free Expert Approved Momentum Trade Ideas - mfd.ru
Published on: 2026-02-02 10:12:16 - baoquankhu1.vn
Rate Hike: What is the next catalyst for TLYSMarket Trend Summary & AI Driven Price Forecasts - baoquankhu1.vn
Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant outperform during market ralliesWeekly Trend Recap & Daily Profit Maximizing Tips - mfd.ru
Retail Trends: What’s the fair value of OSIS stockMarket Sentiment Review & AI Driven Price Predictions - baoquankhu1.vn
Aug Selloffs: Can Reviva Pharmaceuticals Holdings Inc deliver alphaWeekly Trade Recap & Capital Protection Trading Alerts - baoquankhu1.vn
Guidance Update: Is TLRY a good stock for dollar cost averagingTrade Risk Summary & Target Return Focused Stock Picks - baoquankhu1.vn
RVPH Should I Buy - Intellectia AI
Published on: 2026-01-30 02:52:59 - baoquankhu1.vn
Breakout Watch: Does Franklin Wireless Corp have declining or rising EPSEarnings Overview Summary & Smart Investment Allocation Tips - baoquankhu1.vn
Market Leaders: Will DXPRC outperform tech stocks2025 Fundamental Recap & Low Volatility Stock Recommendations - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Tonix Pharma (TNXP), Revolution Medicines (RVMD) and Bausch Health Companies (BHC) - The Globe and Mail
Finanzdaten der Reviva Pharmaceuticals Holdings Inc-Aktie (RVPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):